INTRODUCTIONEfficacy and tolerability of topical treatments for acne and other dermatological conditions are impacted not only by the active drug but also by the vehicle used for its delivery.1,2 For…
Read More
INTRODUCTIONPsoriasis (PsO) is a common, chronic, autoimmunemediated inflammatory disorder associated with significant patient burden, impacting both costs (health care costs, and productivity losses)1 and quality of life.2 Common types of…
Read More
INTRODUCTIONInsect bites not only carry the potential to spread disease but also cause significant discomfort. DEET and other chemical pest-repellents are potentially neurotoxic.1 Natural repellents based on essential oils show…
Read More
INTRODUCTIONThe need for diversification in dermatology has been increasingly highlighted. However, until recently there had been a lack of emphasis on the pathway that unites all physicians: medical education. Fortunately,…
Read More
INTRODUCTIONPsoriasis is a chronic inflammatory skin condition affecting 2% to 3% of the world's population.1,2 The development of the characteristically pruritic plaques is driven by complex immune processes. Although topical…
Read More
INTRODUCTIONInternational Dermatology Outcome Measures (IDEOM) was founded in 2013 to address a need for evidence-based and consensus-driven outcome measures in dermatology.1 Clear outcome measures are critical in dermatology where there…
Read More
INTRODUCTIONThe skin is the second largest organ of the body. It acts as a protective barrier and is a reflection of overall health. This makes the cutaneous conditions different from…
Read More
INTRODUCTIONPsoriasis, a chronic autoimmune skin disease affecting individuals with geographical variations, has multifactorial pathogenesis. Worldwide prevalence is about 2%, but prevalence varies according to the region. The prevalence in Caucasian…
Read More
INTRODUCTIONThe first 1-year training program in Mohs Surgery was established by Dr Perry Robins at NYU in 1970 (Table 1). Several other training programs were established in the 1970s, including…
Read More
INTRODUCTIONTopical calcineurin inhibitors are a family of drugs that have been touted for having high efficacy without the risks of cutaneous atrophy and systemic absorption seen with topical corticosteroids.1 They…
Read More
INTRODUCTIONPsoriasis affects approximately 7.55 million adults in the US and 125 million people worldwide.1,2 Social media, used by approximately 3.6 billion people worldwide in 2020,3 has provided a public forum…
Read More
INTRODUCTIONPsoriasis is a common, chronic inflammatory disease, affecting approximately 2% to 3% of the population over 20 years of age.1,2 This condition is a systemic disease that often causes immune…
Read More
